Global Fluticasone propionate Market
Global Fluticasone propionate Market

Fluticasone propionate Comprehensive Study by Type (60 Metered Sprays, 120 Metered Sprays, 150 Metered Sprays), Application (Adult, Kids) Players and Region - Global Market Outlook to 2024

Fluticasone propionate Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 212 Pages 197 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Fluticasone propionate Market Overview:
Fluticasone propionate is a medication belongs to a corticosteroid class of drugs. It is used in the treatment of allergic rhinitis, asthma, various skin disorders, nasal polyps, ulcerative colitis, and Crohn's disease. Fluticasone propionate market has high growth prospects owing to the increasing prevalence of chronic obstructive pulmonary disease and asthma. In addition, rising demand from the developing economies expected to drive the market demand. Some of the key players profiled in the study are GSK (United Kingdom), Teva Pharmaceutical Industries (Israel), West-Ward Pharmaceuticals (United States), Apotex Corp. (United States), Akorn (United States), Wockhardt (India) and OptiNose US, Inc. (United States).

On the basis of geography, the market of Fluticasone propionate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Drivers
  • Increasing Number of Patients with Asthmatic Condition
  • Growing Demand for Nasal Sprays

Market Trend
  • Increasing Applications in the Treatment of Allergic and Non-Allergic Nasal Indications

Restraints
  • Stringent Government Regulations Regarding Fluticasone Propionate

Opportunities
  • Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD)
  • Increasing Demand from the Developing Economies

Challenges
  • Side Effects Such As Sinusitis, Upper Respiratory Tract Infections, and Others



“According to the National Center for Biotechnology Information, Fluticasone propionate (FP) is a new topical corticosteroid spray used for the treatment of allergic rhinitis and asthma. FP has been shown to be effective for the treatment of adult and pediatric asthma, even at rather low doses (25 microg twice daily [b.i.d.]); many studies in asthma have shown clinical efficacy of fluticasone at half the dose of the comparison steroid (such as beclomethasone dipropionate [BDP] or budesonide [BUD]). However, exact dose comparisons cannot be made because dose-ranging comparison studies have not been done. Studies in allergic rhinitis in children and adults have shown good efficacy in FP-treated patients at a dose of 200 microg once daily (o.d.), intranasally.”

Target Audience:
Fluticasone Propionate Manufacturers, Fluticasone Propionate Distributors, Government Agencies, Commercial Research & Development Institutions, Government Organizations, Research Organizations, and Consulting Firms, Trade Associations and Industry Bodies and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Fluticasone propionate market on the basis of product [60 Metered Sprays, 120 Metered Sprays and 150 Metered Sprays] , application [Adult and Kids], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Fluticasone propionate market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Fluticasone propionate industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Vendors which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Fluticasone propionate market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • 60 Metered Sprays
  • 120 Metered Sprays
  • 150 Metered Sprays
By Application
  • Adult
  • Kids
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Patients with Asthmatic Condition
      • 3.2.2. Growing Demand for Nasal Sprays
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Such As Sinusitis, Upper Respiratory Tract Infections, and Others
    • 3.4. Market Trends
      • 3.4.1. Increasing Applications in the Treatment of Allergic and Non-Allergic Nasal Indications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fluticasone propionate, by Type, Application and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Fluticasone propionate (Value)
      • 5.2.1. Global Fluticasone propionate by: Type (Value)
        • 5.2.1.1. 60 Metered Sprays
        • 5.2.1.2. 120 Metered Sprays
        • 5.2.1.3. 150 Metered Sprays
      • 5.2.2. Global Fluticasone propionate by: Application (Value)
        • 5.2.2.1. Adult
        • 5.2.2.2. Kids
      • 5.2.3. Global Fluticasone propionate Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Fluticasone propionate (Volume)
      • 5.3.1. Global Fluticasone propionate by: Type (Volume)
        • 5.3.1.1. 60 Metered Sprays
        • 5.3.1.2. 120 Metered Sprays
        • 5.3.1.3. 150 Metered Sprays
      • 5.3.2. Global Fluticasone propionate by: Application (Volume)
        • 5.3.2.1. Adult
        • 5.3.2.2. Kids
      • 5.3.3. Global Fluticasone propionate Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Fluticasone propionate (Price)
      • 5.4.1. Global Fluticasone propionate by: Type (Price)
  • 6. Fluticasone propionate: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GSK (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceutical Industries (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. West-Ward Pharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Apotex Corp. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Akorn (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Wockhardt (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. OptiNose US, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Fluticasone propionate Sale, by Type, Application and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Fluticasone propionate (Value)
      • 7.2.1. Global Fluticasone propionate by: Type (Value)
        • 7.2.1.1. 60 Metered Sprays
        • 7.2.1.2. 120 Metered Sprays
        • 7.2.1.3. 150 Metered Sprays
      • 7.2.2. Global Fluticasone propionate by: Application (Value)
        • 7.2.2.1. Adult
        • 7.2.2.2. Kids
      • 7.2.3. Global Fluticasone propionate Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Fluticasone propionate (Volume)
      • 7.3.1. Global Fluticasone propionate by: Type (Volume)
        • 7.3.1.1. 60 Metered Sprays
        • 7.3.1.2. 120 Metered Sprays
        • 7.3.1.3. 150 Metered Sprays
      • 7.3.2. Global Fluticasone propionate by: Application (Volume)
        • 7.3.2.1. Adult
        • 7.3.2.2. Kids
      • 7.3.3. Global Fluticasone propionate Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Fluticasone propionate (Price)
      • 7.4.1. Global Fluticasone propionate by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fluticasone propionate: by Type(USD Million)
  • Table 2. Fluticasone propionate 60 Metered Sprays , by Region USD Million (2013-2018)
  • Table 3. Fluticasone propionate 120 Metered Sprays , by Region USD Million (2013-2018)
  • Table 4. Fluticasone propionate 150 Metered Sprays , by Region USD Million (2013-2018)
  • Table 5. Fluticasone propionate: by Application(USD Million)
  • Table 6. Fluticasone propionate Adult , by Region USD Million (2013-2018)
  • Table 7. Fluticasone propionate Kids , by Region USD Million (2013-2018)
  • Table 8. South America Fluticasone propionate, by Country USD Million (2013-2018)
  • Table 9. South America Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 10. South America Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 11. Brazil Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 12. Brazil Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 13. Argentina Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 14. Argentina Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 15. Rest of South America Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 16. Rest of South America Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 17. Asia Pacific Fluticasone propionate, by Country USD Million (2013-2018)
  • Table 18. Asia Pacific Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 19. Asia Pacific Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 20. China Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 21. China Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 22. Japan Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 23. Japan Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 24. India Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 25. India Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 26. South Korea Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 27. South Korea Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 28. Taiwan Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 29. Taiwan Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 30. Australia Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 31. Australia Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 32. Rest of Asia-Pacific Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 34. Europe Fluticasone propionate, by Country USD Million (2013-2018)
  • Table 35. Europe Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 36. Europe Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 37. Germany Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 38. Germany Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 39. France Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 40. France Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 41. Italy Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 42. Italy Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 43. United Kingdom Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 44. United Kingdom Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 45. Netherlands Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 46. Netherlands Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 47. Rest of Europe Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 48. Rest of Europe Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 49. MEA Fluticasone propionate, by Country USD Million (2013-2018)
  • Table 50. MEA Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 51. MEA Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 52. Middle East Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 53. Middle East Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 54. Africa Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 55. Africa Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 56. North America Fluticasone propionate, by Country USD Million (2013-2018)
  • Table 57. North America Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 58. North America Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 59. United States Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 60. United States Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 61. Canada Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 62. Canada Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 63. Mexico Fluticasone propionate, by Type USD Million (2013-2018)
  • Table 64. Mexico Fluticasone propionate, by Application USD Million (2013-2018)
  • Table 65. Fluticasone propionate Sales: by Type(K Units)
  • Table 66. Fluticasone propionate Sales 60 Metered Sprays , by Region K Units (2013-2018)
  • Table 67. Fluticasone propionate Sales 120 Metered Sprays , by Region K Units (2013-2018)
  • Table 68. Fluticasone propionate Sales 150 Metered Sprays , by Region K Units (2013-2018)
  • Table 69. Fluticasone propionate Sales: by Application(K Units)
  • Table 70. Fluticasone propionate Sales Adult , by Region K Units (2013-2018)
  • Table 71. Fluticasone propionate Sales Kids , by Region K Units (2013-2018)
  • Table 72. South America Fluticasone propionate Sales, by Country K Units (2013-2018)
  • Table 73. South America Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 74. South America Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 75. Brazil Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 76. Brazil Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 77. Argentina Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 78. Argentina Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 79. Rest of South America Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 80. Rest of South America Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 81. Asia Pacific Fluticasone propionate Sales, by Country K Units (2013-2018)
  • Table 82. Asia Pacific Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 83. Asia Pacific Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 84. China Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 85. China Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 86. Japan Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 87. Japan Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 88. India Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 89. India Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 90. South Korea Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 91. South Korea Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 92. Taiwan Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 93. Taiwan Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 94. Australia Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 95. Australia Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 96. Rest of Asia-Pacific Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 97. Rest of Asia-Pacific Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 98. Europe Fluticasone propionate Sales, by Country K Units (2013-2018)
  • Table 99. Europe Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 100. Europe Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 101. Germany Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 102. Germany Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 103. France Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 104. France Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 105. Italy Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 106. Italy Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 107. United Kingdom Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 108. United Kingdom Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 109. Netherlands Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 110. Netherlands Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 111. Rest of Europe Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 112. Rest of Europe Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 113. MEA Fluticasone propionate Sales, by Country K Units (2013-2018)
  • Table 114. MEA Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 115. MEA Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 116. Middle East Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 117. Middle East Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 118. Africa Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 119. Africa Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 120. North America Fluticasone propionate Sales, by Country K Units (2013-2018)
  • Table 121. North America Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 122. North America Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 123. United States Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 124. United States Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 125. Canada Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 126. Canada Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 127. Mexico Fluticasone propionate Sales, by Type K Units (2013-2018)
  • Table 128. Mexico Fluticasone propionate Sales, by Application K Units (2013-2018)
  • Table 129. Fluticasone propionate: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Fluticasone propionate: by Type(USD Million)
  • Table 138. Fluticasone propionate 60 Metered Sprays , by Region USD Million (2019-2024)
  • Table 139. Fluticasone propionate 120 Metered Sprays , by Region USD Million (2019-2024)
  • Table 140. Fluticasone propionate 150 Metered Sprays , by Region USD Million (2019-2024)
  • Table 141. Fluticasone propionate: by Application(USD Million)
  • Table 142. Fluticasone propionate Adult , by Region USD Million (2019-2024)
  • Table 143. Fluticasone propionate Kids , by Region USD Million (2019-2024)
  • Table 144. South America Fluticasone propionate, by Country USD Million (2019-2024)
  • Table 145. South America Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 146. South America Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 147. Brazil Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 148. Brazil Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 149. Argentina Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 150. Argentina Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 151. Rest of South America Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 152. Rest of South America Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 153. Asia Pacific Fluticasone propionate, by Country USD Million (2019-2024)
  • Table 154. Asia Pacific Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 155. Asia Pacific Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 156. China Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 157. China Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 158. Japan Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 159. Japan Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 160. India Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 161. India Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 162. South Korea Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 163. South Korea Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 164. Taiwan Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 165. Taiwan Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 166. Australia Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 167. Australia Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 168. Rest of Asia-Pacific Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 169. Rest of Asia-Pacific Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 170. Europe Fluticasone propionate, by Country USD Million (2019-2024)
  • Table 171. Europe Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 172. Europe Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 173. Germany Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 174. Germany Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 175. France Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 176. France Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 177. Italy Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 178. Italy Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 179. United Kingdom Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 180. United Kingdom Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 181. Netherlands Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 182. Netherlands Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 183. Rest of Europe Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 184. Rest of Europe Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 185. MEA Fluticasone propionate, by Country USD Million (2019-2024)
  • Table 186. MEA Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 187. MEA Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 188. Middle East Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 189. Middle East Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 190. Africa Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 191. Africa Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 192. North America Fluticasone propionate, by Country USD Million (2019-2024)
  • Table 193. North America Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 194. North America Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 195. United States Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 196. United States Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 197. Canada Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 198. Canada Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 199. Mexico Fluticasone propionate, by Type USD Million (2019-2024)
  • Table 200. Mexico Fluticasone propionate, by Application USD Million (2019-2024)
  • Table 201. Fluticasone propionate Sales: by Type(K Units)
  • Table 202. Fluticasone propionate Sales 60 Metered Sprays , by Region K Units (2019-2024)
  • Table 203. Fluticasone propionate Sales 120 Metered Sprays , by Region K Units (2019-2024)
  • Table 204. Fluticasone propionate Sales 150 Metered Sprays , by Region K Units (2019-2024)
  • Table 205. Fluticasone propionate Sales: by Application(K Units)
  • Table 206. Fluticasone propionate Sales Adult , by Region K Units (2019-2024)
  • Table 207. Fluticasone propionate Sales Kids , by Region K Units (2019-2024)
  • Table 208. South America Fluticasone propionate Sales, by Country K Units (2019-2024)
  • Table 209. South America Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 210. South America Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 211. Brazil Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 212. Brazil Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 213. Argentina Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 214. Argentina Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 215. Rest of South America Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 216. Rest of South America Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 217. Asia Pacific Fluticasone propionate Sales, by Country K Units (2019-2024)
  • Table 218. Asia Pacific Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 219. Asia Pacific Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 220. China Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 221. China Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 222. Japan Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 223. Japan Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 224. India Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 225. India Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 226. South Korea Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 227. South Korea Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 228. Taiwan Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 229. Taiwan Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 230. Australia Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 231. Australia Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 232. Rest of Asia-Pacific Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 233. Rest of Asia-Pacific Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 234. Europe Fluticasone propionate Sales, by Country K Units (2019-2024)
  • Table 235. Europe Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 236. Europe Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 237. Germany Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 238. Germany Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 239. France Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 240. France Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 241. Italy Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 242. Italy Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 243. United Kingdom Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 244. United Kingdom Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 245. Netherlands Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 246. Netherlands Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 247. Rest of Europe Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 248. Rest of Europe Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 249. MEA Fluticasone propionate Sales, by Country K Units (2019-2024)
  • Table 250. MEA Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 251. MEA Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 252. Middle East Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 253. Middle East Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 254. Africa Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 255. Africa Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 256. North America Fluticasone propionate Sales, by Country K Units (2019-2024)
  • Table 257. North America Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 258. North America Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 259. United States Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 260. United States Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 261. Canada Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 262. Canada Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 263. Mexico Fluticasone propionate Sales, by Type K Units (2019-2024)
  • Table 264. Mexico Fluticasone propionate Sales, by Application K Units (2019-2024)
  • Table 265. Fluticasone propionate: by Type(USD/Units)
  • Table 266. Research Programs/Design for This Report
  • Table 267. Key Data Information from Secondary Sources
  • Table 268. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fluticasone propionate: by Type USD Million (2013-2018)
  • Figure 5. Global Fluticasone propionate: by Application USD Million (2013-2018)
  • Figure 6. South America Fluticasone propionate Share (%), by Country
  • Figure 7. Asia Pacific Fluticasone propionate Share (%), by Country
  • Figure 8. Europe Fluticasone propionate Share (%), by Country
  • Figure 9. MEA Fluticasone propionate Share (%), by Country
  • Figure 10. North America Fluticasone propionate Share (%), by Country
  • Figure 11. Global Fluticasone propionate: by Type K Units (2013-2018)
  • Figure 12. Global Fluticasone propionate: by Application K Units (2013-2018)
  • Figure 13. South America Fluticasone propionate Share (%), by Country
  • Figure 14. Asia Pacific Fluticasone propionate Share (%), by Country
  • Figure 15. Europe Fluticasone propionate Share (%), by Country
  • Figure 16. MEA Fluticasone propionate Share (%), by Country
  • Figure 17. North America Fluticasone propionate Share (%), by Country
  • Figure 18. Global Fluticasone propionate: by Type USD/Units (2013-2018)
  • Figure 19. Global Fluticasone propionate share by Players 2018 (%)
  • Figure 20. Global Fluticasone propionate share by Players (Top 3) 2018(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. GSK (United Kingdom) Revenue: by Geography 2018
  • Figure 24. Teva Pharmaceutical Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 25. Teva Pharmaceutical Industries (Israel) Revenue: by Geography 2018
  • Figure 26. West-Ward Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 27. West-Ward Pharmaceuticals (United States) Revenue: by Geography 2018
  • Figure 28. Apotex Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Apotex Corp. (United States) Revenue: by Geography 2018
  • Figure 30. Akorn (United States) Revenue, Net Income and Gross profit
  • Figure 31. Akorn (United States) Revenue: by Geography 2018
  • Figure 32. Wockhardt (India) Revenue, Net Income and Gross profit
  • Figure 33. Wockhardt (India) Revenue: by Geography 2018
  • Figure 34. OptiNose US, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. OptiNose US, Inc. (United States) Revenue: by Geography 2018
  • Figure 36. Global Fluticasone propionate: by Type USD Million (2019-2024)
  • Figure 37. Global Fluticasone propionate: by Application USD Million (2019-2024)
  • Figure 38. South America Fluticasone propionate Share (%), by Country
  • Figure 39. Asia Pacific Fluticasone propionate Share (%), by Country
  • Figure 40. Europe Fluticasone propionate Share (%), by Country
  • Figure 41. MEA Fluticasone propionate Share (%), by Country
  • Figure 42. North America Fluticasone propionate Share (%), by Country
  • Figure 43. Global Fluticasone propionate: by Type K Units (2019-2024)
  • Figure 44. Global Fluticasone propionate: by Application K Units (2019-2024)
  • Figure 45. South America Fluticasone propionate Share (%), by Country
  • Figure 46. Asia Pacific Fluticasone propionate Share (%), by Country
  • Figure 47. Europe Fluticasone propionate Share (%), by Country
  • Figure 48. MEA Fluticasone propionate Share (%), by Country
  • Figure 49. North America Fluticasone propionate Share (%), by Country
  • Figure 50. Global Fluticasone propionate: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • GSK (United Kingdom)
  • Teva Pharmaceutical Industries (Israel)
  • West-Ward Pharmaceuticals (United States)
  • Apotex Corp. (United States)
  • Akorn (United States)
  • Wockhardt (India)
  • OptiNose US, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation